Vitamin D Supplementation in Acne

• Status: Not yet recruiting
• Trial end date: 2024-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:

• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.

Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.

Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HITEC-Institute of Medical Sciences
• Treatments: Adapalene; Azithromycin

Criteria

Inclusion Criteria:

• Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.

Exclusion Criteria:

• Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)

• Those with obesity

• Individuals employing vitamin supplementation

• Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.